MX366502B - Composiciones y métodos para tratar heridas superficiales. - Google Patents

Composiciones y métodos para tratar heridas superficiales.

Info

Publication number
MX366502B
MX366502B MX2015009800A MX2015009800A MX366502B MX 366502 B MX366502 B MX 366502B MX 2015009800 A MX2015009800 A MX 2015009800A MX 2015009800 A MX2015009800 A MX 2015009800A MX 366502 B MX366502 B MX 366502B
Authority
MX
Mexico
Prior art keywords
extract
combination
methods
topical
compositions
Prior art date
Application number
MX2015009800A
Other languages
English (en)
Other versions
MX2015009800A (es
Inventor
Gorinshteyn Boris
Original Assignee
Gorinshteyn Boris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51223700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX366502(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gorinshteyn Boris filed Critical Gorinshteyn Boris
Publication of MX2015009800A publication Critical patent/MX2015009800A/es
Publication of MX366502B publication Critical patent/MX366502B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

La invención proporciona composiciones sinérgicas y procedimientos para prevenir y tratar rápidamente heridas dérmicas y úlceras tópicas, de forma eficaz y económica. Comprende una combinación sinérgica de productos naturales, específicamente la combinación de un extracto Hydrastis canadensis, un extracto de una especie del género panax y un extracto de aloe barbadensis L. que están esencialmente libres de extracto de pasiflora incarnata L. La combinación se puede administrar a piel herida y/o a una cavidad tópica en una herida de un paciente como dosis profiláctica o terapéutica y, opcionalmente, se puede proporcionar por medio de un apósito humedecido. La invención proporciona además kits que se pueden usar para la aplicación tópica de la combinación.
MX2015009800A 2013-01-30 2014-01-29 Composiciones y métodos para tratar heridas superficiales. MX366502B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361849590P 2013-01-30 2013-01-30
PCT/US2014/013471 WO2014120700A1 (en) 2013-01-30 2014-01-29 Compositions and methods for treating surface wounds

Publications (2)

Publication Number Publication Date
MX2015009800A MX2015009800A (es) 2016-02-09
MX366502B true MX366502B (es) 2019-07-11

Family

ID=51223700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009800A MX366502B (es) 2013-01-30 2014-01-29 Composiciones y métodos para tratar heridas superficiales.

Country Status (12)

Country Link
US (1) US20140213990A1 (es)
EP (1) EP2950884A4 (es)
JP (1) JP6495183B2 (es)
KR (1) KR20150113035A (es)
CN (1) CN105142728B (es)
AU (1) AU2014212561A1 (es)
CA (1) CA2899661A1 (es)
CL (1) CL2015002146A1 (es)
EA (1) EA032439B9 (es)
GE (1) GEP20197049B (es)
MX (1) MX366502B (es)
WO (1) WO2014120700A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
US20170049749A1 (en) * 2014-02-14 2017-02-23 Scioderm.Inc. Methods for treating burns using allantoin
ES2795671T3 (es) * 2014-12-22 2020-11-24 Cmc Consulting Boston Inc Agente desbridante no enzimático y método de uso del mismo
US11918549B2 (en) 2017-08-25 2024-03-05 AZ Solutions LLC System and method for wound treatment and irrigation
US10960129B2 (en) 2017-08-25 2021-03-30 AZ Solutions LLC System and method for patient skin treatment and irrigation
BR112020003793A2 (pt) * 2017-08-25 2020-10-13 AZ Solutions LLC método para irrigar uma ferida, método de supressão de infecção e sistema de irrigação de ferida
KR102133862B1 (ko) * 2017-11-29 2020-07-14 (주)네추럴에프앤피 시계꽃 추출물을 이용한 세포 생존율 증진용 조성물
CN108392669A (zh) * 2018-03-01 2018-08-14 澳门大学 一种用于创伤修复的生物活性多糖敷料及其制备方法和应用
KR20200047220A (ko) 2018-10-27 2020-05-07 장정훈 창상, 당뇨병성 족부/손 궤양 또는 버거씨병 치료용 약학 조성물
SI25540A (sl) * 2019-01-14 2019-05-31 Tompa Majcen Dominika Formulacije s spojinami aktivnega kisika in pripomočki za njihovo aplikacijo
US11253545B2 (en) * 2019-05-24 2022-02-22 Brian Brazzo Compositions comprising silver nitrate, hyaluronic acid and allantoin and methods for use thereof
KR102072948B1 (ko) 2019-08-06 2020-02-04 주식회사 씨엔엘바이오텍 염증치료용 약학적 발효 조성물
KR102072947B1 (ko) 2019-08-06 2020-02-04 주식회사 씨엔엘바이오텍 상처치유 또는 피부재생 촉진용 약학 조성물
EP3968956B1 (en) * 2019-10-24 2024-04-10 Vishagan Vanangamudi SULUR A topical pharmaceutical mupirocin composition for bacterial infections and wound healing
US20210322462A1 (en) * 2020-04-17 2021-10-21 California Institute Of Technology Wound prevention and/or treatment and related compounds, matrices, compositions, methods and systems
RU2766340C1 (ru) * 2021-02-10 2022-03-15 Игорь Закванович Зайцев Пептидный толерогенный компаунд

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719111A (en) 1985-06-14 1988-01-12 Wilson Lynn M Novel composition for treatment of decubitus ulcers
JP2943247B2 (ja) * 1990-05-31 1999-08-30 藤沢薬品工業株式会社 催眠・鎮静剤
US5846543A (en) * 1995-10-24 1998-12-08 Hassler; Mark A. Bovine mastitis treatment
CN1081066C (zh) * 1999-11-01 2002-03-20 罗泽毅 一种治疗烧烫伤的药物及其制备方法
CN1435228A (zh) * 2002-01-28 2003-08-13 江立生 西洋参喷剂在治疗复发性口腔溃疡中的应用
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
US8999401B2 (en) * 2007-05-09 2015-04-07 Henry Steven Luria Delivery system and method to deliver homeopathic complexes comprising homeopathic colored pigment products for cosmetic use
US7691419B2 (en) * 2007-12-20 2010-04-06 Dileva Rose Marie Compositions and methods for treating skin conditions in mammals
US8591960B2 (en) * 2008-04-22 2013-11-26 Boris Gorinshteyn Composition and method for treating bedsores, cuts and burns
EP2429559A4 (en) * 2009-05-08 2013-08-14 Allmedic Pty Ltd TREATMENT OF PAIN AND / OR INFLAMMATION AS WELL AS TREATMENT AND PREVENTION OF SKIN OR SLICING DISEASES OR TROUBLES
CN103237555B (zh) * 2010-02-19 2015-03-11 玫琳凯有限公司 外用皮肤护理制剂
CA2790682C (en) * 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
KR20140040721A (ko) * 2011-04-21 2014-04-03 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 스킨 케어 제형
ZA201107270B (en) 2011-10-05 2012-06-27 Nozizwe Ndlovu A skin treatment composition

Also Published As

Publication number Publication date
EA201591413A1 (ru) 2015-12-30
EA032439B9 (ru) 2019-08-30
CA2899661A1 (en) 2014-08-07
GEP20197049B (en) 2019-12-10
CN105142728B (zh) 2020-02-14
EP2950884A4 (en) 2016-09-21
KR20150113035A (ko) 2015-10-07
WO2014120700A1 (en) 2014-08-07
EA032439B1 (ru) 2019-05-31
MX2015009800A (es) 2016-02-09
EP2950884A1 (en) 2015-12-09
JP6495183B2 (ja) 2019-04-03
CN105142728A (zh) 2015-12-09
US20140213990A1 (en) 2014-07-31
JP2016506932A (ja) 2016-03-07
AU2014212561A1 (en) 2015-09-10
CL2015002146A1 (es) 2016-04-08

Similar Documents

Publication Publication Date Title
MX2015009800A (es) Composiciones y procedimientos para tratar heridas superficiales.
MX2022013172A (es) Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia.
MX2016007351A (es) Terapia de combinacion para tratar cancer.
BR112015008447A2 (pt) métodos para tratar câncer
MX2016005532A (es) Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.
EP4140487A8 (en) Combination therapy for treating cancer
MX340290B (es) Uso terapéutico de un agonista de receptor tipo toll y terapia de combinación.
NZ716033A (en) Treatment of papulopustular rosacea with ivermectin
MX2017006938A (es) Terapia de combinacion para el tratamiento de cancer.
MX2016004530A (es) Rapamicina para el tratamiento de linfangioleiomiomatosis.
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
MX2018010223A (es) Terapia combinada para tratamiento de cancer de ovario.
MX2019013862A (es) Terapia de combinacion.
MX2018013860A (es) Composiciones cosmeticas para reparacion cutanea.
BR112019006174A2 (pt) proteina terapêutica
WO2018094023A3 (en) Cyclic dipeptides and wound healing
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
WO2014201084A3 (en) Piroxicam transdermal composition to treat plantar fasciitis
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos
PH12015502351A1 (en) Herbal compositions for treating pain and skin disorders
MX2016001177A (es) Tratamiento de esclerosis multiple con la combinacion de laquinimod y flupirtina.
BR112017013282A2 (pt) uso cosmético, processo de cuidado cosmético, extrato de lythrum salicaria e/ou ácido gálico e/ou derivados de ácido gálico, e, extrato ou composição.
WO2019039937A8 (en) POLYTHERAPY FOR THE TREATMENT OF CANCER

Legal Events

Date Code Title Description
FG Grant or registration